Dry Eye

Latest News

Eye drop | Image Credit: © Dragana Gordic
MOJAVE phase 3 study results published

March 22nd 2023

The second pivotal phase 3 data on NOV03 (perfluorohexyloctane) show that NOV30 consistently met primary endpoints for signs and symptoms of dry eye disease associated with Meibomian gland dysfunction.

My practice journey
My practice journey

March 15th 2023

Artificial tear ingredients that mimic the real thing
Artificial tear ingredients that mimic the real thing

March 14th 2023

BRM421 eye drop used for treatment of dry eye disease
First patient enrolled in pivotal phase 3 clinical trial of BRM421 for dry eye disease

March 2nd 2023

Second FDA warning issued on bacterially contaminated eye care products
Second FDA warning issued on bacterially contaminated eye care products

February 23rd 2023

Video Series
Video Interviews
Podcasts

More News

© 2023 MJH Life Sciences

All rights reserved.